Researchers found spinal disinhibition in people with fibromyalgia, adding new clues about the role of central pain ...
The Centers for Medicare and Medicaid Services (CMS) has approved the implants for New Technology Add-on Payment (NTAP).
A Rajya Sabha MP urges the health minister to enable local production of Risdiplam, a vital drug for spinal muscular atrophy, ...
IMC-2017 is under clinical development by ImmuneCyte and currently in Phase I for Spinal Cord Disorders. According to GlobalData, Phase I drugs for Spinal Cord Disorders have an 86% phase transition ...
NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...
The ARC-EX stimulator, recently approved by the FDA, makes it easier for the spinal cord to hear what the brain wants to do ...
Dr. Nitin Dange of Lilavati Hospital briefed the media after Saif's successful surgery and stated, "He has suffered major ...
A Rajya Sabha member has urged the Union health ministry to invoke provisions in Indian patent laws to enable local production of inexpensive generic versions of a medicine for spinal muscular ...
Haris Beeran urges government intervention to make affordable SMA medicines available in India, addressing the high costs and patent issues.
Positive results from its Phase III STEER study mean Novartis could boost sales of its OAV101 IT drug for spinal muscular ...
The landscape of rare diseases is constantly changing as new ailments and conditions are identified and reported regularly.
Novartis AG said a new experimental medicine improved motor function in children with a form of spinal muscular atrophy, the devastating disorder targeted by its gene therapy Zolgensma ...